TREATMENT PATTERN ANALYSIS AND HEALTHCARE RESOURCE CONSUMPTION ON PATIENTS AFFECTED BY PSORIASIS IN APULIA REGION (ITALY).
Author(s)
Perrone V1, Sangiorgi D1, Naclerio M2, Degli Esposti L1
1CliCon S.r.l. Health, Economics & Outcomes Research, Ravenna, Italy, 2Novartis Farma Italy, Origgio (VA), Italy
OBJECTIVES: To analyze the therapeutic and diagnostic pathways for patients affected by psoriasis in Apulia, and to estimate the healthcare resource consumption and related costs for the Italian regional Health System. METHODS: An observational retrospective cohort analysis of administrative database “EDOTTO” of Apulia Region was performed; patients ≥18 years were included if they met one of the following criteria: hospitalization discharge diagnosis of psoriasis (ICD-9-CM 696.1), or exemption code for psoriasis (045.696.1), or a first prescription of a topical antipsoriatic drug (ATC D05A) between 01/01/2010 and 31/12/2015. All patients were followed up for 12 months [from index date (ID) (first match with one of the inclusion criteria) until December 2016]. Type of antipsoriatic drug (topical, DMARD, and biologic), persistence in treatment and annual cost of illness related to the therapeutical strategy applied were analyzed. RESULTS: CONCLUSIONS: This real-world study in Apulia Region showed that, first therapeutical approach in psoriasis patients was topical drugs, however, greater persistence in treatment was observed with biologic drugs. Further research using a larger sample of patients is needed to confirm and contextualize our findings.
Conference/Value in Health Info
2018-11, ISPOR Europe 2018, Barcelona, Spain
Value in Health, Vol. 21, S3 (October 2018)
Code
PSY119
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Systemic Disorders/Conditions